Indeed, Leach et al. showed that enzalutamide, like bicalutamide, another AR antagonist used in cases of hormone-sensitive PCa patients, inhibits SARS-CoV-2 infection in ACE2-transduced A549 lung cells [19]. This evidence concerns the gene AR and posterior cortical atrophy.